PF-06480605

· Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for PF-06480605, covering 2019-06-19 to 2025-12-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of PF-06480605 in Adults With Moderate to Severe Ulcerative Colitis [Phase 2]

See pricing